Back

The additional value of CMR over TTE in mitral regurgitant disease.

2 February 2018 (09:30 - 09:45)
Organised by:
Congress Presentation Part of: Short Lecture 2 - The Role of CMR in Valvular Heart Disease Cardiac Magnetic Resonance (CMR) EACVI Premium Access CMR 2018 (the 5th joint EuroCMR/SCMR meeting)

About the speaker

Photo
Doctor Seth Uretsky

To Be Confirmed (United States of America)

2 More presentations in this session

Presentation thumbnail
The additional value of CMR over TTE in aortic regurgitant disease.
Associate Professor S. Myerson (Oxford, GB)
Slides
Presentation thumbnail
The role of CMR in TAVI planning and follow-up .
Professor G. Pontone (Milan, IT)
Slides

Access the full session

Session thumbnail
Short Lecture 2 - The Role of CMR in Valvular Heart Disease

The Event

Event poster

CMR 2018 (the 5th joint EuroCMR/SCMR meeting)

2 February 2018 09:30 CET
You may be interested in
thumbnail
Congress Session
How to approach a patient with functional mitral regurgitation
19 May 2025
thumbnail
Congress Presentation
Accuracy of echocardiographic parameters in the diagnosis of severe mitral regurgitation as determined by cardiac magnetic resonance imaging.
11 December 2024
thumbnail
Congress Presentation
Prognostic implications of mitral regurgitation in heart failure patients undergoing cardiac resynchronization therapy.
22 May 2023
thumbnail
Congress Presentation
The role of cleft and/or indentation in mitral regurgitation etiology detected by three-dimensional echocardiography in patients with hypertrophic cardiomyopathy
11 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources